瘤内及瘤周影像组学预测接受铂类化疗的高级别浆液性卵巢癌患者预后
研究基于两家机构474例回顾性收集的平扫CT,训练并验证深度学习预后模型,评估瘤内及瘤周影像组学预测接受铂类化疗的高级别浆液性卵巢癌患者结局的价值。采用1像素瘤周扩展的ROI模型预测无进展生存表现最佳,训练集、内部测试集和外部测试集的HR分别为3.41、1.14和1.32,高危及低危组生存差异显著。
要点
- 1像素瘤周扩展的ROI输入配置预测准确性最高。
- 模型预测无进展生存:训练集HR 3.41,内部测试集HR 1.14,外部测试集HR 1.32。
- 高危及低危组间KM生存分析差异显著(P < 0.05)。
核心结论
- 深度学习模型可有效预测接受铂类化疗的高级别浆液性卵巢癌患者的生存结局,为预后评估和个体化治疗规划提供有价值的信息。
研究设计与样本
- 回顾性收集两家机构474例患者的平扫CT,分为训练集362例、内部测试集86例和外部测试集26例,训练并验证深度学习预后模型。
诊断标准与关键数值
- 模型采用肿瘤分割及瘤周区域分析,输入配置包括原始肿瘤ROI、ROI亚区域及ROI分别扩展1和3像素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to develop a deep learning (DL) prognostic model to evaluate the significance of intra- and peritumoral radiomics in predicting outcomes for high-grade serous ovarian cancer (HGSOC) patients receiving platinum-based chemotherapy.
MATERIALS AND METHODS: A DL model was trained and validated on retrospectively collected unenhanced computed tomography (CT) scans from 474 patients at two institutions, which were divided into a training set (N = 362), an internal test set (N = 86), and an external test set (N = 26). The model incorporated tumor segmentation and peritumoral region analysis, using various input configurations: original tumor regions of interest (ROIs), ROI subregions, and ROIs expanded by 1 and 3 pixels. Model performance was assessed via hazard ratios (HRs) and receiver operating characteristic (ROC) curves. Patients were stratified into high- and low-risk groups on the basis of the training set's optimal cutoff value.
RESULTS: Among the input configurations, the model using an ROI with a 1-pixel peritumoral expansion achieved the highest predictive accuracy. The DL model exhibited robust performance for predicting progression-free survival, with HRs of 3.41 (95% CI: 2.85, 4.08; P < 0.001) in training set, 1.14 (95% CI: 1.03, 1.26; P = 0.012) in internal test set, and 1.32 (95% CI: 1.07, 1.63; P = 0.011) in external test set. KM survival analysis revealed significant differences between the high-risk and low-risk groups (P < 0.05).
CONCLUSION: The DL model effectively predicts survival outcomes in HGSOC patients receiving platinum-based chemotherapy, offering valuable insights for prognostic assessment and personalized treatment planning.
引用
- Huang X, Huang Y, Liu K, et al. Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy. Acad Radiol. 2024. PMID: 39289095. doi:10.1016/j.acra.2024.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。